14Mar 2018

IMMUNOPHENOTYPIC ANALYSIS OF ACUTE PROMYELOCYTIC LEUKEMIA AT A TERTIARY CARE INSTITUTE.

  • Senior Resident, Department of Hematopathology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Associate Professor, Department of Clinical Hematology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Professor and Head, Department of Clinical Hematology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Additional Professor, Department of Clinical Hematology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Senior Resident, Department of Clinical Hematology, Sher-I-Kashmir Institute of Medical Sciences, Srinagar, India.
Crossref Cited-by Linking logo

  • References
  • Cite This Article as
  • Corresponding Author
  1. Arber D.A., Brunning R.D., Le Beau M.M., Falini B., Vardiman J.W., Porwit A., et al. Acute myeloid leukaemia with recurrent genetic abnormalities. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 20168; 134-136
  2. Exner M, Thalhammer R, Kapiotis S, et al. The ?typical? immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant? Cytometry. 2000;42:106-109.
  3. [3]Orfao A, Chillo? n MC, Bortoluci AM, et al. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARa gene rearrangements. Haematologica 1999;84:405?412.
  4. Edgar G. Rizzatti, Fernando L. Portieres, Se?rgio L.R. Martins, Eduardo M. Rego, Marco A. Zago, and Roberto P. Falca. Microgranular and t(11;17)/PLZF-RARa Variants of Acute Promyelocytic Leukemia Also Present the Flow Cytometric Pattern of CD13, CD34, and CD15 Expression Characteristic of PML-RARa Gene Rearrangement. American Journal of Hematology 76:44?51 (2004)
  5. Pedro Horna, Ling Zhang, Eduardo M. Sotomayor, Jeffrey E. Lancet, and Lynn C. Moscinski.Diagnostic Immunophenotype of Acute Promyelocytic Leukemia Before and Early During Therapy With All-trans Retinoic Acid Am J Clin Pathol October 2014;142:546-552.
  6. I. Ahmad, H. Akl, M. E.Hashem, and T. A. M. Elgohary. The biological characteristics of adult CD34+ acute Promyelocytic leukemia. Medical Oncology, vol. 29, no. 2, pp. 1119?1126, 2012.
  7. Pei Lin, Suyang Hao, L. Jeffrey Medeiros, Elihu H. Estey, Sherry A. Pierce, Xuemei Wang, et al. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PMLRAR 𝛼 transcripts and poorer prognosis. American Journal of Clinical Pathology, vol. 121, no. 3, pp. 402?407, 2004.
  8. Gorczyca. Acute promyelocytic leukemia: four distinct patterns by flow cytometry Immunophenotyping. Polish Journal of Pathology, vol. 63, no. 1, pp. 8?17, 2012.
  9. Y. Dong, J. X. Kung, V. Bhardwaj, and J. McGill. Flow cytometry rapidly identifies all acute promyelocytic leukemias with high specificity independent of underlying cytogenetic abnormalities. American Journal of Clinical Pathology, vol. 135, no. 1, pp. 76?84, 2011.
  10. Liu Y,?Chen YT,?Li JX and Zhang SH. Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia. Journal of Experimental Hematology, vol. 20, no. 4, pp. 806?811, 2012.
  11. Liang JY,?Wu DP,?Liu YJ,?Ma QF,?Gong JX,?Zhu MQ et al. The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases. Zhonghua nei ke za zhi, vol. 47, no. 5, pp. 389?392, 2008.
  12. Lee JJ,?Cho D,?Chung IJ,?Cho SH,?Park KS,?Park MR,?et al. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia. Am J Hematol. 2003;73:149-153.
  13. Foley R,?Soamboonsrup P,?Carter RF,?Benger A,?Meyer R,?Walker I,?et al. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform. Am J Hematol. 2001;67:34-41.
  14. Albano F,?Mestice A,?Pannunzio A,?Lanza F,?Martino B,?Pastore D,et al?.The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34- CD2- hypergranular (M3) and microgranular (M3v) phenotypes. Haematologica, vol. 91, no. 3, pp. 311?316, 2006.
  15. Breccia M,?Avvisati G,?Latagliata R,?Carmosino I,?Guarini A,?De Propris MS et al. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia, vol. 21, no. 1, pp. 79?83, 2007.
  16. Murray CK, Estey E, Paietta E, Howard RS, Edenfield WJ, Pierce S et al. CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome? J Clin Oncol 1999; 17: 293?297.)
  17. Montesinos P,?Ray?n C,?Vellenga E,?Brunet S,?Gonz?lez J,?Gonz?lez M et al. Clinical significance of CD56 expression in patients with acute Promyelocytic leukemia treated with all-trans retinoic acid and anthracyclinebased regimens. Blood, vol. 117, no. 6, pp. 1799?1805, 2011.
  18. Paietta E,?Andersen J,?Gallagher R,?Bennett J,?Yunis J,?Cassileth P, et al. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.. 1994 Jul;8(7):1108-12.
  19. Fang Xu, Chang-Xin Yin, Chun-Li Wang, Xue-Jie Jiang, Ling Jiang, Zhi-XiangWang, et al. Immunophenotypes and Immune Markers Associated with Acute Promyelocytic Leukemia Prognosis. Disease Markers, vol. 2014, Article ID 421906, 6 pages, 2014.

[Shuaeb Bhat, Saleem Hussain, Sajad Geelani, Javid Rasool, Aleem Jan, Fahim Manzoor, Shareefa Akther, Humaira Bashir, Noor Jahan, Subuh Pervez, Shazieya Akhtar, Sumaiya Shah, Sadaqat Mir, Arjumand Yaqoob, Zubair Ahmad. (2018); IMMUNOPHENOTYPIC ANALYSIS OF ACUTE PROMYELOCYTIC LEUKEMIA AT A TERTIARY CARE INSTITUTE. Int. J. of Adv. Res. 6 (Mar). 1039-1042] (ISSN 2320-5407). www.journalijar.com

Dr SHAREEFA AKTHER
Senior Resident Hematolgy,SKIMS, Soura,Srinagar, J&K

DOI:

Article DOI: 10.21474/IJAR01/6763      
DOI URL: https://dx.doi.org/10.21474/IJAR01/6763

Download Full Paper

Download PDF No. of Downloads: 13 | No. of Views: 83